301 related articles for article (PubMed ID: 3276900)
21. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
[TBL] [Abstract][Full Text] [Related]
22. An analysis of survival and treatment failure following abdominoperineal and sphincter-saving resection in Dukes' B and C rectal carcinoma. A report of the NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project.
Wolmark N; Fisher B
Ann Surg; 1986 Oct; 204(4):480-9. PubMed ID: 3532972
[TBL] [Abstract][Full Text] [Related]
23. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
24. [Developments up to now and current status of adjuvant chemo- and radiotherapy in colonic and rectal carcinoma].
Kraus TW; Eble MJ; Raeth U
Langenbecks Arch Chir; 1994; 379(6):353-7. PubMed ID: 7845161
[TBL] [Abstract][Full Text] [Related]
25. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
Cafiero F; Gipponi M; Lionetto R;
J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
[TBL] [Abstract][Full Text] [Related]
26. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
27. Accomplishments in surgical adjuvant therapy for large bowel cancer.
Moertel CG
Cancer; 1992 Sep; 70(5 Suppl):1364-71. PubMed ID: 1511386
[TBL] [Abstract][Full Text] [Related]
28. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
29. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.
Fisher B; Dignam J; Mamounas EP; Costantino JP; Wickerham DL; Redmond C; Wolmark N; Dimitrov NV; Bowman DM; Glass AG; Atkins JN; Abramson N; Sutherland CM; Aron BS; Margolese RG
J Clin Oncol; 1996 Jul; 14(7):1982-92. PubMed ID: 8683228
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant therapy in colorectal cancer.
Gerard A; Metzger U; Buyse M
Anticancer Res; 1989; 9(4):1033-5. PubMed ID: 2683989
[TBL] [Abstract][Full Text] [Related]
31. NCI advocates use of adjuvant therapy for rectal cancer.
Am Fam Physician; 1991 Apr; 43(4):1440-2, 1444. PubMed ID: 2008825
[No Abstract] [Full Text] [Related]
32. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
Kemeny N; Yagoda A; Braun D
Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant therapy for rectal cancer in the elderly.
Cohen SM; Neugut AI
Drugs Aging; 2004; 21(7):437-51. PubMed ID: 15132712
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience.
Thomas PR; Lindblad AS
Radiother Oncol; 1988 Dec; 13(4):245-52. PubMed ID: 3064191
[TBL] [Abstract][Full Text] [Related]
35. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
[TBL] [Abstract][Full Text] [Related]
37. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
Kodaira S; Shatari T; Nozawa K
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data.
Breugom AJ; Swets M; Bosset JF; Collette L; Sainato A; Cionini L; Glynne-Jones R; Counsell N; Bastiaannet E; van den Broek CB; Liefers GJ; Putter H; van de Velde CJ
Lancet Oncol; 2015 Feb; 16(2):200-7. PubMed ID: 25589192
[TBL] [Abstract][Full Text] [Related]
39. [Adjuvant chemotherapy in rectal cancer].
Schmoll HJ
Chirurg; 1994 Jul; 65(7):576-84. PubMed ID: 7924595
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02.
Wolmark N; Rockette H; Wickerham DL; Fisher B; Redmond C; Fisher ER; Potvin M; Davies RJ; Jones J; Robidoux A
J Clin Oncol; 1990 Sep; 8(9):1466-75. PubMed ID: 2202789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
